Pharmacoepidemiology Seminars and Speakers, 1997-1998



The Pharmacoepidemiology Lecture Series is sponsored by the Department of Epidemiology through Dr. Walker.  The purpose of the The Pharmacoepidemiology Lecture Series is to invite distinguished lecturers to HSPH who are working in an academic, industry or government environment, whose work/research focuses on the epidemiology
of drug utilization and the intended and unintended effects of pharmaceutical and medical procedures.

LOCATION:       Epidemiology Library
                            Harvard School of Public Health
                            677 Huntington Avenue
                            Room  904, Kresge Building
                            Boston, MA 02115

TIME:                  12:30-1:30

Do you want to be included in a mailing list on upcoming events?



Wednesday, June 3rd, 1998 12:30-1:30

Speaker:             Alexander Walker, MD, DrPH
                          Chairman, Dept. of Epidemiology
                          Harvard School of Public Health
                          Pharmacoepidemiology Program

TITLE:               An Epidemiologist Faces up to ADRs
 

Friday, May 15th, 1998 12:30-1:30

SPEAKER:        Joerg Hasford, MD PhD
                          University of Munich
                          Dept. of Medical Information Processing, Biometry and Epidemiology
                          Head, Pharmacoepidemiology Research Group

TITLE:               PEGASUS:  A cohort study of drug utilization during pregnancy and fetal outcome.
 
 

Wednesday, May 6, 1998 12:30-1:30

SPEAKER:        Robert T. Chen, MD MA
                          Chief
                          Vaccine Safety and Development Activity
                          National Immunization Program, CDC, Atlanta, GA
 
TITLE:               Vaccine Safety
 
 

Friday, April 24, 1998 (Room: Kresge 204) 12:30-1:30

SPEAKER:        Susanne Prez Gutthann,  MD, MPH
                          Head, Global Pharmacoepidemiology, Novartis Pharmaceuticals
                          Barcelona, Spain

TITLE:               Applications of Epidemiology in the Pharmaceutical Field. An Industry Perspective
 
 

Wednesday, April 8, 1998 12:30-1:30

SPEAKER:    Saga Johansson, PhD
                      Director, Pharmacoepidemiology
                      Astra Hässle, Sweden

TITLE:           Epidemiology in the Pharmaceutical Industry
 
 

Wednesday, March 18, 1998 (tentative)

SPEAKER:    Elizabeth Andrews, PhD
                      Director, Worldwide Epidemiology
                      Glaxo Wellcome Co.
                      Research Triangle Park, North Carolina

TITLE:           Data Privacy
 
 

Wednesday, March 11, 1998

SPEAKER:    Dr. Jerry Avorn
                      Associate Professor of Medicine Harvard Medical School
                      and
                      Chief Division of Pharmaco-Epidemiology
                      Brigham and Women's Hospital

TITLE:           The New Division of Pharmaco-Epidemiology at the Brigham:
                      Opportunities, Fantasies, Challenges, and Risks.
 
 

Wednesday, February 11, 1998

SPEAKER:    Edward Bortnichak, MPH, PhD
                      Director, Department of Safety Surveillance,
                      Epidemiology & Medical Information
                      Berlex Laboratories
                      Wayne, New Jersey

TITLE:           A Case Study of Diclofenac Sodium

 

Wednesday, January 14, 1998

SPEAKER:      Dr. Allen Mitchell
                        Slone Epidemiology Unit
                        Boston University
                        School of Public Health & Medicine

TITLE:             Case-Control Surveillance for Birth Defects
 

 
Monday, December 8, 1997:
 
SPEAKER:      Dr. Malcolm Maclure
                        Pharmacare, British Columbia Ministry of Health, Canada
                        Adjunct Associate Professor of Epidemiology, Harvard School of Public Health

TITLE:             The Role of the Epidemiologist in making Drug
                        Benefits Policy Evaluable
 

Wednesday, November 12, 1997:

SPEAKER:      Dr. Christoph R. Meier
                        Boston Collaborative Drug Surveillance Program
                        Boston University Medical Center

TITLE:             Tamoxifen and the Risk of Developing Idiopathic
                        Venous Thromboembolism
 



Do you want to be included in a mailing list on upcoming events?

Please send an e-mail to:                   majordomo@hsphsun2.harvard.edu
                Message text:                   subscribe pharmepi
                                                                           Note: no subject, no other text


If you have questions or comments about the Seminars,  please send an e-mail to Linda Marc

Return to the top of this document

Return to DDIL HOMEPAGE

This document has been provided through the Drugs and Devices Information Line, http://www.hsph.harvard.edu/Organizations/DDIL/ddil.html
If you have questions or comments about the DDIL, please write to: sschneew@hsph.harvard.edu